Skip to main content
. 2023 Apr 23;15(9):2425. doi: 10.3390/cancers15092425
ALK Anaplastic lymphoma kinase
AMP Association for Molecular Pathology
BRAF v-raf murine sarcoma viral oncogene homolog B1
CAP College of American Pathologists
cfDNA Cell-free DNA
ctDNA Circulating-tumour DNA
CI Confidence interval
CNV Copy number variation
ddPCR Droplet digital polymerase chain reaction
ECOG Eastern Cooperative Oncology Group
EGFR Epidermal growth factor receptor
HER2 Human epidermal growth factor receptor 2
HR Hazard ratio
IASLC International Association for the Study of Lung Cancer
KRAS Kirsten rat sarcoma
LB Liquid biopsy
MeSH Medical subject headings
MET Mesenchymal–epithelial transition factor
mOS Medial overall survival
mPFS Median progression-free survival
MRD Minimal residual disease
NGS Next-generation sequencing
NSCLC Non-small-cell lung cancer
NOS Newcastle–Ottawa Scale
NTRK Neurotrophic tyrosine receptor kinase
ORR Overall response rate
OS Overall survival
PCR Polymerase chain reaction
PD-L1 Programmed-death-ligand 1
PFS Progression-free survival
pHR Pooled hazard ratio
PRISMA Preferred Reporting Items for Systemic Review and Meta-Analyses
RET Rearranged during transfection
ROS-1 C-ros oncogene 1
TKI Tyrosine kinase inhibitor
TSG Tumour suppressor gene
VAF Variant allele frequency